Brief: Dermtech Will Discontinue Optional Tert Promoter Mutation Add-On Assay For Its Dermtech Melanoma Test Effective March 1, 2024

DermTech

16/01/2024 13:06

Jan 16 (Reuters) - DermTech Inc  DMTKW.PK :
    * DERMTECH SIMPLIFIES THE DERMTECH MELANOMA TEST (DMT) BY
DISCONTINUING THE OPTIONAL TERT ADD-ON ASSAY
    * DERMTECH INC: WILL DISCONTINUE OPTIONAL TERT PROMOTER
MUTATION
ADD-ON ASSAY FOR ITS DERMTECH MELANOMA TEST (DMT) EFFECTIVE
MARCH 1, 2024
    * DERMTECH INC: TRUST 2 STUDY CONFIRMS NEGATIVE PREDICTIVE
VALUE
(NPV) OF 99.7% FOR FOUNDATIONAL GENE EXPRESSION ASSAY

Source text for Eikon:  ID:nBw4tWFs7a 
Further company coverage:  DMTKW.PK 

 ((Reuters.Briefs@thomsonreuters.com;))